LIDEFARMA

LIDEFARMA has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €315,147 and a net result of €62,177. Equity is growing by about 7% per year across the filed financial years. Its solvency ranks better than 76% of 22,595 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).